HALOZYME REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS
Go back to HALOZYME REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 107.39 -0.92 (0.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.31 | 52 Week High | $18.39 | |||
| Open | $107.67 | 52 Week Low | $6.96 | |||
| Day High | $108.79 | P/E | N/A | |||
| Day Low | $106.62 | EPS | $-0.58 | |||
| Volume | 1,697,819 | |||||
